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Abstract
Introduction: The frequency of intra-orbital metastasis in systemic cancer is a controversial topic. Of all metastatic 
tumors to the orbit of the eye, breast carcinoma is considered to be the most prevalent. Orbital findings typically 
present themselves after the diagnosis of the primary tumor, with an average delay of three to six years. In spite of that, 
this study reports a case in which orbital manifestation was the initial symptom in breast carcinoma diagnosis.
Case presentation: A 66-year-old Italian Caucasian woman presented with a swelling located on the lower orbit of her 
right eye.
Conclusions: Previous cases report orbital manifestations discovered secondary to breast cancer. This case 
demonstrates that orbital symptoms may be the primary presentation of the disease. Orbital metastasis originating 
from breast cancer predicts widespread metastatic disease in other organs. In the presence of an ambiguous infiltrative 
orbital process, diagnostic examination of the breast is recommended.
Introduction
The most frequent sites in which breast carcinoma
metastases occur are the liver, bone, lungs, skin and
brain. The orbit is only associated with the spread of the
disease in a small percentage of cases.
The frequency of intra-orbital metastasis in systemic
cancer is a controversial topic: some authors relate an
incidence of up to 30% [1]; others believe it occurs in
approximately 2% to 3% of cases [2,3].
Of all metastatic tumors to the orbit - as reported in
several studies [2-5] - breast carcinoma is considered to
be the most prevalent primary tumor, calculated as 29%
to 70% of all orbital metastases.
A recent study by the Institute of Ophthalmology and
Visual Science of New Jersey Medical School argues that
orbital findings typically present after diagnosis of the
primary tumor, with an average delay of three to six years;
although occasionally orbital metastasis may become
apparent decades after the initial diagnosis of breast can-
cer [2].
This study reports a case from the Department of Sur-
gery of the University of Genoa in which orbital manifes-
tation was the initial sign in breast carcinoma diagnosis.
Case presentation
Our patient was a 66-year-old Italian Caucasian woman
with an insignificant past medical history.
She presented with a swelling located on the lower orbit
of her right eye, not associated with visual disorders.
Computed tomography (CT) of the orbits revealed a
thickening of her right peri-orbital soft tissues and a poor
cleavage between adipose tissue, optic nerve and muscu-
lature, suggesting, on initial observation, differential diag-
noses of infiltrative process (lymphoma?) and
inflammatory pathology. Laboratory data only revealed
an increased alkaline phosphatase (ALP) value (345 U/L).
Physical examination showed the presence of a lesion
located on the external side of the left breast.
At the Breast Unit our patient underwent standard pre-
operative investigations -mammography, ultrasound
examination and fine needle aspiration cytology of the
lesion - showing a poorly differentiated breast carcinoma.
No neoadjuvant chemotherapy treatment was sug-
gested for our patient, who instead underwent a modified
radical mastectomy and a biopsy of the peri-orbital tissue
of her upper and lower eyelid.
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Microscopic examination of the specimen led to the
diagnosis of invasive lobular breast cancer with a massive
metastatic involvement of all the 16 axillary lymph nodes,
neural, vascular, and lymphatic invasion (UICC: T3/G3/
N3a); in the peri-orbital tissue a widespread carcinoma-
tous infiltration was shown by seal ring cells compatible
with breast invasive lobular carcinoma derivation (UICC:
T3/G3/N3a/M1).
Immunohistochemical evaluation was positive for
estrogen receptor (ER: 75%) and progesterone receptor
(PgR: 60%). Ki-67 proliferation index was favorably low
(5%) and the oncoprotein c-erb-2 was negative (score 0).
Our patient underwent systemic oncologic evaluation
(including total body CT scan and bone scintigraphy),
which revealed the probable involvement of skull, first
left rib, sternum-clavicular joint, dorsal rachis and bilat-
eral iliac crests (so explaining the rise of ALP value).
Blood values of carcinoembryonic antigen (CEA) rose to
20.0 μg/L and cancer antigen (CA) 15.3 to 188.00 U/mL.
Our patient received adjuvant chemotherapy (5-fluo-
rouracil, epirubicin and cyclophosphamide (FEC) and
docetaxel for three cycles) and eye radiation therapy.
Because she underwent surgery fewer than five years ago,
she is still under hormonal therapy (aromatase inhibitor
for five years).
Discussion
Previous cases report that orbital manifestation is usually
discovered secondary to breast cancer [2,4,6-8]. This case
- the first in 20 years experience of our Unit - demon-
strates that orbital symptoms may be the primary presen-
tation of the disease.
According to our findings, the agreement of histologi-
cal features shows that invasive lobular carcinoma is the
most common histotype in breast cancer metastatic to
the orbit [5,9,10].
Orbital metastasis originating from breast cancer pre-
dicts widespread metastatic disease in other organs [2,4-
6]. In our patient the systematic evaluation confirmed
that metastatic spreading included several bone areas
and, with reasonable suspicion, the lungs.
Our patient is monitored with annual nuclear magnetic
resonance imaging of the breast, a checkwise surgical and
oncological examination every six months, blood value of
CEA and CA 15.3, total body and orbital examination
every four months.
Conclusions
Breast cancer presentation is not always straight forward.
A patient may not detect a palpable mass.
A symptom, not strictly associated with breast cancer,
brought our patient to seek medical advice. Therefore, in
the presence of an ambiguous infiltrative orbital process,
differential diagnosis must include breast cancer and
diagnostic breast examination is highly recommended.
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